XLO – xilio therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI [Yahoo! Finance]
Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI 
Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer [Yahoo! Finance]
Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer
After Golden Cross, Xilio Therapeutics, Inc. (XLO)'s Technical Outlook is Bright [Yahoo! Finance]
Form 4 Xilio Therapeutics, Inc. For: Dec 18 Filed by: GILEAD SCIENCES, INC.
Form SCHEDULE 13G/A Xilio Therapeutics, Inc. Filed by: GILEAD SCIENCES, INC.
Form 8-K Xilio Therapeutics, Inc. For: Dec 18
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Bain Capital Life Sciences Fund II, L.P.
Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.